Table 5 Adverse events after treatment with EE/CMA or EE/DRSP

From: A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

Adverse event EE /CMA
n (%)
EE /DRSP
n (%)
Breast pain 12 (13.3) 12 (13.3)
Headache 6 (6.7) 9 (10.0)
Nausea 9 (10.0) 8 (8.9)
Dizziness 11 (12.2) 11 (12.2)
Fever 8 (8.9) 3 (3.3)
Flatulence 1 (1.1) 2 (2.2)
Stomachache 2 (2.2) 0 (0.0)
Diarrhea 2 (2.2) 2 (2.2)
Pelvic pain 1 (1.1) 4 (4.4)
Vomiting 2 (2.2) 1 (1.1)
Excessive hungry 4 (4.4) 3 (3.3)
  1. Note: No significant difference between treatment groups